Literature DB >> 11358358

Analysis of the NRAMP1 gene implicated in iron transport: association with multiple sclerosis and age effects.

M J Kotze1, J N de Villiers, R N Rooney, J J Grobbelaar, E P Mansvelt, C S Bouwens, J Carr, I Stander, L du Plessis.   

Abstract

Multiple sclerosis (MS) is believed to be an autoimmune process occurring in genetically susceptible individuals after an appropriate environmental exposure. We have exploited the homogeneous Afrikaner population of European ancestry to investigate the likelihood that iron dysregulation, in association with infectious and/or autoimmune disease susceptibility, may underlie the MS phenotype in a subgroup of patients. The functional Z-DNA forming repeat polymorphism of the natural resistance-associated macrophage protein-1 (NRAMP1) gene was analyzed in 104 patients diagnosed with MS and 522 Caucasian controls. A family-based control group consisting of 32 parental alleles not transmitted to MS offspring was additionally studied to exclude the likelihood of population substructures. Statistically significant differences in allelic distribution were observed between the patient and control samples drawn from the same population (P < 0.01). Evidence is furthermore provided that alleles considered to be detrimental in relation to autoimmune disease susceptibility may be maintained in the population as a consequence of improved survival to reproductive age following infectious disease challenge. Although it remains to be determined whether the disease phenotype in MS patients with allele 5 of the NRAMP1 promoter polymorphism is directly related to dysregulation of iron or modified susceptibility to viral infection and/or autoimmunity, a combination of these processes most likely underlies the disease phenotype in these patients. In view of the emerging role of polymorphic variants in complex diseases and minimizing of possible confounding factors in this association study, we conclude that allelic variation in the NRAMP1 promoter may contribute significantly to MS susceptibility in the South African Caucasian population. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11358358     DOI: 10.1006/bcmd.2000.0349

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  22 in total

1.  Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity.

Authors:  Robert A Bermel; Srinivas R Puli; Richard A Rudick; Bianca Weinstock-Guttman; Elizabeth Fisher; Frederick E Munschauer; Rohit Bakshi
Journal:  Arch Neurol       Date:  2005-09

Review 2.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

3.  Iron and the folate-vitamin B12-methylation pathway in multiple sclerosis.

Authors:  S J van Rensburg; M J Kotze; D Hon; P Haug; J Kuyler; M Hendricks; J Botha; F C V Potocnik; T Matsha; R T Erasmus
Journal:  Metab Brain Dis       Date:  2006-05-26       Impact factor: 3.584

4.  Solute carrier family 11 member A1 gene polymorphisms in reactive arthritis.

Authors:  Yi-Jing Chen; Chia-Hui Lin; Tsan-Teng Ou; Cheng-Chin Wu; Wen-Chan Tsai; Hong-Wen Liu; Jeng-Hsien Yen
Journal:  J Clin Immunol       Date:  2007-01-09       Impact factor: 8.317

5.  SLC11A1 polymorphisms in inflammatory bowel disease and Mycobacterium avium subspecies paratuberculosis status.

Authors:  Lucy C Stewart; Andrew S Day; John Pearson; Murray L Barclay; Richard B Gearry; Rebecca L Roberts; Robert W Bentley
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

6.  Lack of clinical manifestation of hereditary haemochromatosis in South African patients with multiple sclerosis.

Authors:  Maritha J Kotze; J Nico P de Villiers; Louise Warnich; Stephen Schmidt; Jonathan Carr; Erna Mansvelt; Elba Fourie; Susan J van Rensburg
Journal:  Metab Brain Dis       Date:  2006-07-19       Impact factor: 3.584

7.  The -237C-->T promoter polymorphism of the SLC11A1 gene is associated with a protective effect in relation to inflammatory bowel disease in the South African population.

Authors:  Monique G Zaahl; Trevor A Winter; Louise Warnich; Maritha J Kotze
Journal:  Int J Colorectal Dis       Date:  2005-07-30       Impact factor: 2.571

8.  NRAMP1 (SLC11A1) variants: genetic susceptibility to multiple Sclerosis.

Authors:  Omer Ates; Semiha Kurt; Nihan Bozkurt; Hatice Karaer
Journal:  J Clin Immunol       Date:  2010-04-20       Impact factor: 8.317

9.  NRAMP1 (SLC11A1): a plausible candidate gene for systemic sclerosis (SSc) with interstitial lung involvement.

Authors:  O Ates; B Müsellim; G Ongen; A Topal-Sarikaya
Journal:  J Clin Immunol       Date:  2007-09-18       Impact factor: 8.317

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.